A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

NCT05539963 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Osteomyelitis

Interventions

DRUG: STIMULAN VG
DRUG: Systemic Antibiotics

Sponsor

Biocomposites Ltd

Collaborators

[object Object]